Skip to content 
CSL has reached the upper end of its trading range. In line with our commitment to optimizing returns and managing risks effectively, we are taking profit on the remaining 2% of our CSL position.
Take Profit Telix Pharma (TLX) in our balanced portfolio, we will take half our allocation for a 15.8% profit as we see the overall market underperforming in the next couple of weeks.
A recent rally in the underlying Uranium price has seen the spot price rally from $80 to a fresh 16-year of $104. We have hit profit target for Deep Yellow and taken a 26% profit on the trade.
A recent rally in the underlying Uranium price. The we have hit the recent highs for Paladin and recommend taking our position off as it has hit profit target.
Sell 2.5% holding in Ventia services for 10% profit
A recent rally in the underlying Uranium price. The we have hit the recent highs for Paladin and recommend taking half our position off for a quick scalp.
